Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Leids Universitair Medisch Centrum”

3 pharma patents match "Leids Universitair Medisch Centrum" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Leids Universitair Medisch Centrum" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Leids Universitair Medisch Centrum” · 30,257 patents in full index Clear search

  1. US 11352389

    Treatment of haematological malignancies

    Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Jun 7, 2022 · Expires Jun 2, 2042

    granted

  2. US 11246947

    Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

    Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Feb 15, 2022 · Expires Feb 10, 2042

    granted

  3. US 7560105

    Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses

    Leids Universitair Medisch Centrum · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.